NCT04382469

Brief Summary

Background: Corona virus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose: To give initial experience about COVID-19 in Alexandria-Egypt describing radiological patterns of lung involvement, also surveying prevalence of co-morbid lung diseases and their effect on COVID-19 presentation. Methods: Retrospective study including 48 patients with positive polymerase chain reaction (PCR) test for COVID-19 during the period from February 2020 till May 2020 in Alexandria/Egypt. Full clinical and laboratory data are obtained. High resolution computed tomography (HRCT) findings are described. Serial follow up studies are done. Surveying co-morbid lung diseases done including tuberculosis (TB), interstitial lung diseases (ILDs), chronic obstructive lung disease (COPD), immune and vascular-related diseases. Prevalence rate is the predominant analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2020

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

3 months

First QC Date

May 5, 2020

Last Update Submit

May 10, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Radiological pattern of initial presentation, disease progress, healing and recovery

    HRCT findings

    "through study completion, an average of 1 month"

  • Survey of co-morbid lung diseases

    prevalence

    "through study completion, an average of 1 month"

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care centers

You may qualify if:

  • Positive COVID-19

You may not qualify if:

  • Incomplete medical records, degrade CT images because of patient tachypnea and motions artifacts, also unremarkable CT scans.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, University of Alexandria

Alexandria, 21526, Egypt

Location

Study Officials

  • Ahmed Samir, MD

    Department of Radio-diagnosis.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of radio-diagnosis

Study Record Dates

First Submitted

May 5, 2020

First Posted

May 11, 2020

Study Start

February 1, 2020

Primary Completion

April 30, 2020

Study Completion

May 1, 2020

Last Updated

May 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

The investigators will recommend further large group future researches for some notices in the study, but preferably not be biased

Locations